Results 71 to 80 of about 3,398 (179)

Unmasking a Rare Genetic Puzzle: Hereditary Hemorrhagic Telangiectasia in a Black Kenyan Woman: A Case Report

Case Reports in Gastrointestinal Medicine, Volume 2026, Issue 1, 2026.
Background Hereditary hemorrhagic telangiectasia (HHT) is a rare genetic disorder characterized by mucocutaneous and visceral telangiectasias, often leading to severe complications. This case report presents an uncommon manifestation of HHT in a 57‐year‐old Black Kenyan female with upper gastrointestinal bleeding. Given the rarity of HHT in our region,
Lavender Otom, Priyanka Panwar, Farida Kaittany, Ben Clement Lomatayo, Yoshifumi Nakayama   +4 more
wiley   +1 more source

Extravasation of Intravenous Iron: Clinical Features and Therapeutic Considerations

Case Reports in Hematology, Volume 2026, Issue 1, 2026.
Iron deficiency anemia is a common condition that can be effectively treated with intravenous iron supplementation; however, extravasation during administration represents a relevant adverse effect. This case series presents three patients with varying underlying conditions who experienced iron extravasation following ferric carboxymaltose infusion ...
Bilge Ada Özcan, Fadime Yılmaz, Abidin Gündoğdu, Gokhan Tazegul, Zekaver Odabaşı, Rounak Dubey   +5 more
wiley   +1 more source

Expert Consensus on the Significance of Intravenous Iron using Ferric Carboxymaltose Perioperatively and in Elective Major Orthopedic Surgeries

Anemia has emerged as a significant healthcare crisis in India and often remains undiagnosed, with broad implications across all age groups. Iron deficiency remains the most important and correctable cause of anemia in our country.
Sachin Suryawanshi, Miten Sheth, Punit Jain, Surendar Singh Bava, Swarnendu Samanta, Attique Vasdev, Anand Galagali, Satish Sonar, Prashant Tonape, Ketan Kulkarni, Atul Panghate, Mohan Desai, K R Prathap Kumar, Ashraf Shaikh, Santhosh Shetty, Ashish Arbat   +15 more
core   +1 more source

Safety and efficacy of ferric carboxymaltose in children and adolescents with iron deficiency anemia

, 2017
Safety and efficacy of ferric carboxymaltose in children and adolescents with iron deficiency ...
Mantadakis, Elpis, Elpis Mantadakis, Jelena Roganovic, Roganović, Jelena   +3 more
core   +1 more source

Safety of rapid injection of undiluted ferric carboxymaltose to patients with iron-deficiency anaemia: a Phase II single-arm study

, 2021
BACKGROUND: Ferric carboxymaltose is increasingly utilised to treat iron deficiency and is usually diluted in saline and administered as an intravenous infusion over 15 min.
Bennett, A, van Dam, M, Indran, T, Gilbertson, M, Dev, A, Chunilal, S, Coughlin, E, Pasricha, SR, Opat, S   +8 more
core   +1 more source

Intravenous ferric carboxymaltose versus oral ferrous sulphate for the treatment of moderate to severe postpartum anaemia in Nigerian women (IVON-PP): protocol for an open-label randomised controlled type 1 hybrid effectiveness-implementation trial

BMJ Open
Introduction Postpartum anaemia is often caused by iron deficiency with onset during the antepartum period and can be exacerbated by excessive blood loss at birth. Its prevalence is estimated as 50–80% in low-income and middle-income countries.
Mobolanle Balogun, Aduragbemi Banke-Thomas, Ejemai Amaize Eboreime, Kate Walker, Folasade Ogunsola, Eleanor J Mitchell, Bosede Bukola Afolabi, Titilope Adenike Adeyemo, Ochuwa Adiketu Babah, Victoria Olawunmi Adaramoye, Opeyemi Rebecca Akinajo, Ibraheem Ajibola Abioye, Chisom Florence Chieme, Yewande Oshodi, Rachel Quao   +14 more
doaj   +1 more source

Budget Impact of Intravenous Iron Therapy with Ferric Carboxymaltose in Patients with Chronic Heart Failure and Iron Deficiency in Romania

Journal of Cardiovascular Emergencies, 2019
Background: Ferric carboxymaltose (FCM) treatment in case of iron deficient (ID) patients with chronic heart failure (CHF) has shown great promise according to the findings of recent studies in improvement of symptoms and quality of life, New York Heart ...
Lorenzovici László, Székely Andrea, Farkas-Ráduly Szabolcs, Jitaru Ciprian, Csanádi Marcell   +4 more
doaj   +1 more source

Update of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practice

Therapeutics and Clinical Risk Management, 2011
Sunil BhandariDepartment of Renal Medicine, Hull and East Yorkshire Hospitals National Health Service Trust and Hull York Medical School, Kingston upon Hull, UKBackground: The clinical need to be able to administer high doses of intravenous iron ...
Bhandari S
doaj  

Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose

, 2017
Objective: Oral iron substitution has shown to be insufficient for treatment of severe iron deficiency anemia in pregnancy. Ferric carboxymaltose is a new intravenous (i.v.) iron formulation promising to be more effective and as safe as iron sucrose.
Studer, Hanna, Irion, Olivier, De Tejada, Begoña Martinez, Schuller, Christine, Christoph, Patricia, Surbek, Daniel   +5 more
core  

Evaluation of efficacy of injection ferric carboxymaltose in pregnant women

, 2020
Background: Iron deficiency anaemia (IDA) continues to be a very common problem in developing countries leading to a spectrum of adverse events in pregnant women.
Wani, Reena J., Sabale, Rupali M., Jalvee, Rashmi   +2 more
core   +1 more source